BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 29921294)

  • 1. Trigger factor assisted self-assembly of canine parvovirus VP2 protein into virus-like particles in Escherichia coli with high immunogenicity.
    Nan L; Liu Y; Ji P; Feng H; Chen C; Wang J; Liu D; Cui Y; Wang Y; Li Y; Zhou E; Zhang G
    Virol J; 2018 Jun; 15(1):103. PubMed ID: 29921294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-assembly of virus-like particles of canine parvovirus capsid protein expressed from Escherichia coli and application as virus-like particle vaccine.
    Xu J; Guo HC; Wei YQ; Dong H; Han SC; Ao D; Sun DH; Wang HM; Cao SZ; Sun SQ
    Appl Microbiol Biotechnol; 2014 Apr; 98(8):3529-38. PubMed ID: 24413974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Porcine parvovirus capsid protein expressed in Escherichia coli self-assembles into virus-like particles with high immunogenicity in mice and guinea pigs.
    Ji P; Liu Y; Chen Y; Wang A; Jiang D; Zhao B; Wang J; Chai S; Zhou E; Zhang G
    Antiviral Res; 2017 Mar; 139():146-152. PubMed ID: 28063996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large-scale manufacture of VP2 VLP vaccine against porcine parvovirus in Escherichia coli with high-density fermentation.
    Wang J; Liu Y; Chen Y; Wang A; Wei Q; Liu D; Zhang G
    Appl Microbiol Biotechnol; 2020 May; 104(9):3847-3857. PubMed ID: 32130468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunogenicity of the virus-like particles derived from the VP2 protein of porcine parvovirus.
    Hua T; Zhang D; Tang B; Chang C; Liu G; Zhang X
    Vet Microbiol; 2020 Sep; 248():108795. PubMed ID: 32827923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Display of neutralizing epitopes of Canine parvovirus and a T-cell epitope of the fusion protein of Canine distemper virus on chimeric tymovirus-like particles and its use as a vaccine candidate both against Canine parvo and Canine distemper.
    Chandran D; Shahana PV; Rani GS; Sugumar P; Shankar CR; Srinivasan VA
    Vaccine; 2009 Dec; 28(1):132-9. PubMed ID: 19818723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An oral Sindbis virus replicon-based DNA vaccine containing VP2 gene of canine parvovirus delivered by Escherichia coli elicits immune responses in dogs.
    Dahiya SS; Saini M; Kumar P; Gupta PK
    Acta Virol; 2011; 55(4):289-94. PubMed ID: 22149493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two potential recombinant rabies vaccines expressing canine parvovirus virion protein 2 induce immunogenicity to canine parvovirus and rabies virus.
    Luo J; Shi H; Tan Y; Niu X; Long T; Zhao J; Tian Q; Wang Y; Chen H; Guo X
    Vaccine; 2016 Aug; 34(37):4392-8. PubMed ID: 27449079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canine parvovirus VP2 protein expressed in silkworm pupae self-assembles into virus-like particles with high immunogenicity.
    Feng H; Hu GQ; Wang HL; Liang M; Liang H; Guo H; Zhao P; Yang YJ; Zheng XX; Zhang ZF; Zhao YK; Gao YW; Yang ST; Xia XZ
    PLoS One; 2014; 9(1):e79575. PubMed ID: 24465364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Administration with Vaccinia Virus Encoding Canine Parvovirus 2
    Zhao W; Wang X; Li Y; Li Y
    Viral Immunol; 2020; 33(6):434-443. PubMed ID: 32364832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of virus-like particles containing modified goose parvovirus VP2 protein.
    Chen Z; Li C; Zhu Y; Wang B; Meng C; Liu G
    Virus Res; 2012 Oct; 169(1):306-9. PubMed ID: 22940567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-assembled raccoon dog parvovirus VP2 protein confers immunity against RDPV disease in raccoon dogs: in vitro and in vivo studies.
    Xia L; Luo G; Wu M; Wang L; Zhang N; Wu C; Yin Y
    Virol J; 2021 Apr; 18(1):79. PubMed ID: 33858464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction and Immunogenicity of Virus-Like Particles of Feline Parvovirus from the Tiger.
    Jiao C; Zhang H; Liu W; Jin H; Liu D; Zhao J; Feng N; Zhang C; Shi J
    Viruses; 2020 Mar; 12(3):. PubMed ID: 32188011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of canine IL-2 and IL-7 genes on enhancing immunogenicity of canine parvovirus VP2 gene vaccine in mice].
    Chen H; Zhong F; Li X; Wang L; Sun Y; Neng C; Zhang K; Li W; Wen J
    Wei Sheng Wu Xue Bao; 2012 Nov; 52(11):1392-9. PubMed ID: 23383511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunodetection of Canine Parvovirus (CPV) in clinical samples by polyclonal antisera against CPV-VP2 protein expressed in Esherichia coli as an antigen.
    Park JS; Choi BK; Vijayachandran LS; Ayyappan V; Chong CK; Lee KS; Kim SC; Choi CW
    J Virol Methods; 2007 Dec; 146(1-2):281-7. PubMed ID: 17825928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of the immunogenicity of the VP2 protein of canine parvovirus produced using an improved Baculovirus expression system.
    Chang D; Liu Y; Chen Y; Hu X; Burov A; Puzyr A; Bondar V; Yao L
    BMC Vet Res; 2020 Jun; 16(1):202. PubMed ID: 32552679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Canine Parvovirus is diagnosed and neutralized by chicken IgY-scFv generated against the virus capsid protein.
    Ge S; Xu L; Li B; Zhong F; Liu X; Zhang X
    Vet Res; 2020 Sep; 51(1):110. PubMed ID: 32883344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of immune responses induced by porcine parvovirus virus-like particles and inactivated vaccine.
    Tian W; Qiu Z; Cui Y; Zhang J; Ma X; Cui S; Zheng S
    Pak J Pharm Sci; 2019 Jan; 32(1(Special)):377-382. PubMed ID: 30852473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient expression and purification of porcine circovirus type 2 virus-like particles in Escherichia coli.
    Wu PC; Chen TY; Chi JN; Chien MS; Huang C
    J Biotechnol; 2016 Feb; 220():78-85. PubMed ID: 26795354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-yield production of canine parvovirus virus-like particles in a baculovirus expression system.
    Jin H; Xia X; Liu B; Fu Y; Chen X; Wang H; Xia Z
    Arch Virol; 2016 Mar; 161(3):705-10. PubMed ID: 26666439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.